Funds holding BioNTech SE
ISIN US09075V1026 · Germany · LEI 894500UZJ5LG1F8J1U58
- Fund holders
- 142
- Of which ETFs
- 30 112 other funds
- Value held
- ≈ 1.7B $ 1.7B $ · 287.9M SEK · 1.1M €
142 funds hold this company. This table lists the 137 that declare it in a regulatory filing. The other 5 publish their holdings in their own reports. The “Fund reports” tab lists them, with their weight.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Fidelity Climate Action Fund Fidelity Summer Street Trust | 2,447 | 234.8K $ | 0.40 % | as of May 31, 2026 ↗ |
| Baillie Gifford International Alpha ETF Baillie Gifford ETF Trust | 2,008 | 186.8K $ | 0.28 % | as of Jun 30, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 2,000 | 186.1K $ | 0.11 % | as of Jun 30, 2026 ↗ |
| NYLIM Candriam International Equity ETF NYLIM ETF Trust | 1,976 | 179.7K $ | 0.07 % | as of Jul 31, 2026 ↗ |
| EUROPE 30 PROFUND ProFunds | 1,884 | 170.7K $ | 1.86 % | as of Jul 31, 2026 ↗ |
| SA Multi-Managed Mid Cap Value Portfolio SEASONS SERIES TRUST | 1,777 | 165.3K $ | 0.08 % | as of Jun 30, 2026 ↗ |
| ALGER RESPONSIBLE INVESTING FUND ALGER FUNDS II | 1,722 | 156K $ | 0.12 % | as of Jul 31, 2026 ↗ |
| Franklin Allocation VIP Fund Franklin Templeton Variable Insurance Products Trust | 1,720 | 160K $ | 0.03 % | as of Jun 30, 2026 ↗ |
| Biotechnology Fund Rydex Variable Trust | 1,678 | 156.1K $ | 1.16 % | as of Jun 30, 2026 ↗ |
| Goldman Sachs MarketBeta Total International Equity ETF Goldman Sachs ETF Trust II | 1,545 | 147.8K $ | 0.02 % | as of May 29, 2026 ↗ |
| BlackRock Balanced Portfolio BlackRock Series Fund, Inc. | 1,379 | 128.3K $ | 0.03 % | as of Jun 30, 2026 ↗ |
| Länsförsäkringar Globala Mål Index Länsförsäkringar Fondförvaltning AB | 1,369 | 1.1M SEK | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex International Focused Index Fund Fidelity Salem Street Trust | 1,237 | 112K $ | 0.07 % | as of Jul 31, 2026 ↗ |
| Calvert International Responsible Index ETF Morgan Stanley ETF Trust | 1,200 | 111.7K $ | 0.03 % | as of Jun 30, 2026 ↗ |
| Health Care Fund Rydex Series Funds | 1,196 | 111.3K $ | 0.57 % | as of Jun 30, 2026 ↗ |
| JNL/Mellon World Index Fund JNL Series Trust | 1,072 | 99.7K $ | 0.01 % | as of Jun 30, 2026 ↗ |
| Global Atlantic BlackRock Disciplined Core Portfolio Forethought Variable Insurance Trust | 1,008 | 93.8K $ | 0.01 % | as of Jun 30, 2026 ↗ |
| Health Care Fund Rydex Variable Trust | 776 | 72.2K $ | 0.69 % | as of Jun 30, 2026 ↗ |
| Innovator International Developed Managed Floor ETF Innovator ETFs Trust | 774 | 70.4K $ | 0.08 % | as of Jul 31, 2026 ↗ |
| Langar Global Health Tech ETF SPINNAKER ETF SERIES | 767 | 71.4K $ | 2.88 % | as of Jun 30, 2026 ↗ |
| iShares Health Innovation Active ETF BlackRock ETF Trust | 705 | 63.9K $ | 0.57 % | as of Jul 31, 2026 ↗ |
| Invesco Income Advantage U.S. Fund AIM Counselor Series Trust (Invesco Counselor Series Trust) | 685 | 65.7K $ | 0.03 % | as of May 31, 2026 ↗ |
| UBS GLOBAL ALLOCATION FUND UBS FUNDS | 540 | 50.7K $ | 0.03 % | as of Jun 30, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 252 | 23.4K $ | 0.88 % | as of Jun 30, 2026 ↗ |
| E*TRADE No Fee International Index Fund E Trade Trust | 234 | 21.2K $ | 0.03 % | as of Jul 31, 2026 ↗ |
| MFS Global Alternative Strategy Fund MFS Series Trust XV | 232 | 21K $ | 0.01 % | as of Jul 31, 2026 ↗ |
| Handelsbanken Global Index Core Handelsbanken Fonder AB | 217 | 180.8K SEK | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD DEVELOPED MARKETS EX-US GROWTH INDEX ETF VANGUARD WORLD FUND | 208 | 20K $ | 0.06 % | as of May 31, 2026 ↗ |
| SA JPMorgan Diversified Balanced Portfolio SUNAMERICA SERIES TRUST | 174 | 15.8K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 126 | 11.7K $ | 0.06 % | as of Jun 30, 2026 ↗ |
| Innovator International Developed Managed 10 Buffer ETF Innovator ETFs Trust | 92 | 8.4K $ | 0.06 % | as of Jul 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 47 | 4.4K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| WAM HIGH CONVICTION, FI WELCOME ASSET MANAGEMENT, SGIIC, S.A. | 510.6K € | 1.57 % | as of Dec 31, 2025 ↗ | |
| ARBITRAGE CAPITAL, SICAV, S.A. RENTA 4 GESTORA, S.G.I.I.C., S.A. | 244.1K € | 0.27 % | as of Dec 31, 2025 ↗ | |
| KOALA CAPITAL SICAV, S.A. GESIURIS ASSET MANAGEMENT, SGIIC, S.A. | 218.8K € | 0.92 % | as of Dec 31, 2025 ↗ | |
| EKO INVESTMENT CAPITAL SICAV SA SINGULAR ASSET MANAGEMENT, SGIIC, S.A. | 97.3K € | 0.34 % | as of Dec 31, 2025 ↗ | |
| MERCH-EUROUNION, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 72.9K € | 1.62 % | as of Dec 31, 2025 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Echiquier Health Impact for All La Financière de l'Échiquier | 2.55 % | as of Jun 30, 2025 ↗ |
| Edmond de Rothschild Fund - Healthcare Edmond de Rothschild Asset Management (Luxembourg) | 2.31 % | as of Mar 31, 2026 ↗ |
| Echiquier World Equity Growth La Financière de l'Échiquier | 2.23 % | as of Mar 31, 2026 ↗ |
| Carmignac Portfolio Grande Europe Carmignac Gestion Luxembourg S.A. | 1.48 % | as of Dec 31, 2025 ↗ |
| Carmignac Portfolio Patrimoine Europe Carmignac Gestion Luxembourg S.A. | 0.29 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 3.41 % | as of May 31, 2026 ↗ |
| Langar Global Health Tech ETF SPINNAKER ETF SERIES | 2.88 % | as of Jun 30, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 2.63 % | as of Jun 30, 2026 ↗ |
| Echiquier Health Impact for All La Financière de l'Échiquier | 2.55 % | as of Jun 30, 2025 ↗ |
| Edmond de Rothschild Fund - Healthcare Edmond de Rothschild Asset Management (Luxembourg) | 2.31 % | as of Mar 31, 2026 ↗ |
| Echiquier World Equity Growth La Financière de l'Échiquier | 2.23 % | as of Mar 31, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 1.94 % | as of Jun 30, 2026 ↗ |
| EUROPE 30 PROFUND ProFunds | 1.86 % | as of Jul 31, 2026 ↗ |
| PROFUND VP EUROPE 30 ProFunds | 1.85 % | as of Jun 30, 2026 ↗ |
| MERCH-EUROUNION, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 1.62 % | as of Dec 31, 2025 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 121 | -20 | 17,822,647 | -15.4 % |
| 2026Q2 | 141 | +6 | 21,055,737 | +10.9 % |
| 2026Q1 | 135 | -18 | 18,986,471 | -4.0 % |
| 2025Q4 | 153 | -14 | 19,772,784 | +19.0 % |
| 2025Q3 | 167 | +11 | 16,611,285 | +6.6 % |
| 2025Q2 | 156 | -4 | 15,579,722 | +6.1 % |
| 2025Q1 | 160 | +37 | 14,679,590 | +20.3 % |
| 2024Q4 | 123 | +28 | 12,197,517 | +23.4 % |
| 2024Q3 | 95 | +12 | 9,883,719 | -4.6 % |
| 2024Q2 | 83 | 0 | 10,361,530 | +0.2 % |
| 2024Q1 | 83 | -5 | 10,340,942 | +2.0 % |
| 2023Q4 | 88 | 10,136,650 |
Institutional managers
271 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 5,856,073 | 520.5K $ | as of Mar 31, 2026 |
| FMR LLC | 5,709,240 | 507.4M $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 3,793,711 | 337.2M $ | as of Mar 31, 2026 |
| FLOSSBACH VON STORCH SE | 3,680,315 | 327.1M $ | as of Mar 31, 2026 |
| Dodge & Cox | 3,676,791 | 326.8M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 1,658,153 | 147.4M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 1,651,789 | 146.8M $ | as of Mar 31, 2026 |
| Temasek Holdings (Private) Ltd | 1,506,027 | 133.9M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 951,372 | 84.6M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 903,029 | 80.3M $ | as of Mar 31, 2026 |
| GSK plc | 889,824 | 79.1M $ | as of Mar 31, 2026 |
| BAILLIE GIFFORD & CO | 882,572 | 78.4M $ | as of Mar 31, 2026 |
| FIRST TRUST ADVISORS LP | 839,991 | 74.7M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 783,995 | 69.7M $ | as of Mar 31, 2026 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 670,514 | 59.6M $ | as of Mar 31, 2026 |
| Long Focus Capital Management, LLC | 624,000 | 55.5M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 488,367 | 43.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 482,411 | 42.9M $ | as of Mar 31, 2026 |
| DekaBank Deutsche Girozentrale | 481,397 | 42.1K $ | as of Mar 31, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | 476,923 | 42.4M $ | as of Mar 31, 2026 |
| TANG CAPITAL MANAGEMENT LLC | 470,000 | 41.8M $ | as of Mar 31, 2026 |
| DEUTSCHE BANK AG\ | 391,689 | 34.8M $ | as of Mar 31, 2026 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 387,214 | 34.4M $ | as of Mar 31, 2026 |
| LBP AM SA | 385,109 | 34.2M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 384,626 | 34.2M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding BioNTech SE". https://titelia.com/en/stocks/biontech-se-US09075V1026